LON:POLX Polarean Imaging (POLX) Share Price, News & Analysis GBX 0.08 -0.02 (-20.00%) As of 12/22/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About Polarean Imaging Stock (LON:POLX) Get Polarean Imaging alerts:Sign Up Key Stats Today's Range 0.06▼ 0.1350-Day Range 0.08▼ 0.0852-Week Range 0.06▼ 1.60Volume28.96 million shsAverage Volume7.19 million shsMarket Capitalization£965.63 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Polarean is a revenue-generating medical imaging technology company revolutionizing pulmonary medicine through direct visualization of lung function by introducing the power and safety of MRI to the respiratory healthcare community. This community is in desperate need of modern solutions to accurately assess lung function. The Company strives to optimize lung health and prevent avoidable loss by illuminating hidden disease, addressing the global unmet medical needs of more than 500 million patients worldwide suffering from chronic respiratory disease. Polarean is a leader in the field of hyperpolarization science and has successfully developed the first and only hyperpolarized Xenon MRI inhaled contrast agent, XENOVIEW™, which is now FDA-approved in the United States. Polarean is dedicated to researching, developing, and commercialising innovative imaging solutions with its non-invasive and radiation-free pulmonary functional MRI platform. This comprehensive drug-device platform encompasses the proprietary Xenon gas blend, gas hyperpolarization system, as well as software and accessories, facilitating fully integrated modern respiratory imaging operations. Founded in 2012, with offices in Durham, NC, and London, United Kingdom, Polarean is committed to increasing global awareness of and broad access to its XENOVIEW MRI technology platform. For the latest news and information about Polarean, please visit www.polarean.com Read More Receive POLX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Polarean Imaging and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. POLX Stock News HeadlinesKorean distributor agreement with DK Healthcare in South KoreaNovember 24, 2025 | markets.businessinsider.comPolarean Imaging Expands into South Korea with DK Healthcare PartnershipNovember 24, 2025 | tipranks.comI was right about SpaceXJeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.May 28 at 1:00 AM | Brownstone Research (Ad)Polarean Imaging Shares Plunge as Company Considers Delisting to Cut CostsOctober 22, 2025 | marketwatch.comPolarean Imaging Expands US Market Reach with Ascend Imaging PartnershipOctober 6, 2025 | msn.comPolarean Imaging Faces Market Challenges but Expands Strategic PartnershipsSeptember 25, 2025 | msn.comFDA expands XENOVIEW® indication to include children from six years of ageJune 2, 2025 | finance.yahoo.comPolarean Imaging’s Xenon MRI gains traction in pulmonary medicineMay 17, 2025 | uk.investing.comSee More Headlines POLX Stock Analysis - Frequently Asked Questions How have POLX shares performed this year? Polarean Imaging's stock was trading at GBX 0.08 at the start of the year. Since then, POLX shares have increased by 0.0% and is now trading at GBX 0.08. How do I buy shares of Polarean Imaging? Shares of POLX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Polarean Imaging own? Based on aggregate information from My MarketBeat watchlists, some other companies that Polarean Imaging investors own include SSP Group (SSPG), Intel (INTC), ASOS (ASC), B&M European Value Retail (BME), BP (BP) and Coats Group (COA). Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolLON:POLX CIKN/A Webwww.polarean.com Phone919 206 7900FaxN/AEmployees28Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (0.10) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£69.44 million Net Margins-373.62% Pretax MarginN/A Return on Equity-73.99% Return on Assets-32.28% Debt Debt-to-Equity Ratio5.59 Current Ratio3.56 Quick Ratio9.80 Sales & Book Value Annual Sales£2.56 million Price / Sales0.38 Cash FlowGBX 0.02 per share Price / Cash Flow4.93 Book ValueGBX 3.30 per share Price / Book0.02Miscellaneous Outstanding Shares1,207,033,000Free FloatN/AMarket Cap£965.63 thousand OptionableNot Optionable Beta0.38 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (LON:POLX) was last updated on 5/28/2026 by MarketBeat.com Staff. From Our PartnersThe "hidden" half of the SpaceX IPOMost investors are focused on the SpaceX IPO - but the bigger opportunity may lie elsewhere. On Feb. 2, Elon M...Weiss Ratings | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredWhen SpaceX goes public your retirement pays the priceWhen SpaceX files its S-1, institutions will liquidate holdings, rebalance portfolios, and free up capital for...Reagan Gold Group | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | SponsoredA 25,000% opportunityAngel investor Jason Calacanis - who made a fortune on an early Uber stake - says Elon Musk's latest project c...The Oxford Club | SponsoredHow daily 'stock bets' hit 87% of the timeA daily trading system claims an 87% win rate on short-term stock plays - and it runs just one hour a day, fro...Trade To Close | SponsoredThis Tech Could Be Bigger Than Apple, Amazon, and Microsoft CombinedA breakthrough technology backed by Elon Musk, Sam Altman, and Nvidia CEO Jensen Huang may hold the answer to ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Polarean Imaging plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Polarean Imaging With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.